ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Tarceva and Targretin in Stage I-II Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00125372
Recruitment Status : Completed
First Posted : August 1, 2005
Last Update Posted : July 15, 2014
Sponsor:
Collaborators:
Ligand Pharmaceuticals
Genentech, Inc.
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2010
  Actual Study Completion Date : August 2010